MedTrace Logo

Predictors of Coronary Revascularization Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

NCT04354740 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-04-22

No results posted yet for this study

Summary

* To explore the metabolic outcomes of PCI versus CABG in diabetic patients presented by ACS.
* To verify the diagnostic and prognostic value of speckle tracking echocardiography in early detection of MACE after ACS in diabetic patients treated by 2 modalities.

Conditions

  • Diabetes Mellitus, Type 2 With Acute Coronary Syndrom

Interventions

PROCEDURE

with percutaneous coronary intervention (PCI) are with new-generation drug-eluting stents (DES)

II-PCI: -Coronary angiography and intervention will be done according to the European guidelines of ACS revascularization. III-CABG:

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2021-06-30
Completion
2021-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04354740 on ClinicalTrials.gov